Valued Retirements’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$232K Buy
252
+27
+12% +$27.4K 0.23% 86
2025
Q4
$242K Buy
+225
New +$215K 0.24% 81
2024
Q4
Sell
-371
Closed -$328K 80
2024
Q3
$328K Hold
371
0.45% 54
2024
Q2
$336K Hold
371
0.51% 49
2024
Q1
$288K Hold
371
0.46% 48
2023
Q4
$216K Buy
+371
New +$217K 0.37% 59

Other funds holding LLY

Valued Retirements's LLY Position: Q1 2026 in Review

Valued Retirements increased its Eli Lilly (LLY) stake by 12% in Q1 2026, buying an estimated $27.4K and bringing the position to 252 shares worth $232K. The position accounts for 0.23% of the portfolio, ranked #86.

Valued Retirements first reported a position in LLY in Q4 2023 and has held it in 6 quarters since. The position peaked at $336K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Valued Retirements held 252 shares of Eli Lilly worth $232K as of Q1 2026.
  • Valued Retirements bought 27 Eli Lilly shares in Q1 2026, an estimated $27.4K.
  • Eli Lilly made up 0.23% of Valued Retirements's portfolio in Q1 2026, its #86 holding.
  • Valued Retirements first reported a position in Eli Lilly in Q4 2023 and has held it in 6 quarters since.
  • Valued Retirements's Eli Lilly position peaked at $336K in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Valued Retirements's 13F filing for Q1 2026, filed 13 May 2026.